Palo Alto Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$717K Buy
726
+18
+3% +$13.4K 0.21% 30
2025
Q2
$552K Sell
708
-4
-0.6% -$3.11K 0.21% 31
2025
Q1
$532K Buy
712
+20
+3% +$16.6K 0.21% 29
2024
Q4
$535K Buy
+692
New +$573K 0.19% 28

Other funds holding LLY

Palo Alto Wealth Advisors's LLY Position: Q3 2025 in Review

Palo Alto Wealth Advisors increased its Eli Lilly (LLY) stake by 2.5% in Q3 2025, buying an estimated $13.4K and bringing the position to 726 shares worth $717K. The position accounts for 0.21% of the portfolio, ranked #30.

Palo Alto Wealth Advisors first reported a position in LLY in Q4 2024 and has held it in 4 quarters since. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Palo Alto Wealth Advisors held 726 shares of Eli Lilly worth $717K as of Q3 2025.
  • Palo Alto Wealth Advisors bought 18 Eli Lilly shares in Q3 2025, an estimated $13.4K.
  • Eli Lilly made up 0.21% of Palo Alto Wealth Advisors's portfolio in Q3 2025, its #30 holding.
  • Palo Alto Wealth Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 4 quarters since.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Palo Alto Wealth Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.